TMRW Life Sciences

TMRW Life Sciences

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $102M

Overview

TMRW Life Sciences is a private, commercial-stage company offering a comprehensive digital platform for automated fertility specimen storage. Its core technology integrates RFID-enabled cryo-storage hardware (robots, vaults, biorepositories) with a HIPAA-compliant cloud software suite (ivfOS) to provide a complete digital chain of custody and real-time monitoring. The company targets in-vitro fertilization (IVF) clinics seeking to reduce operational risk, optimize lab space, and scale their storage capacity while offering patients greater transparency and security for their stored genetic material. TMRW's solutions are deployed with leading fertility clinic networks across the United States.

Fertility

Technology Platform

Integrated digital platform combining RFID-enabled cryogenic storage hardware (CryoRobot, Vault), cloud-based specimen management software (ivfOS), and 24/7 remote monitoring (Overwatch®) for automated, traceable storage of eggs, embryos, and sperm.

Funding History

3
Total raised:$102M
Series B$65M
Series A$25M
Seed$12M

Opportunities

The rapidly growing demand for fertility preservation and IVF, driven by social trends and delayed parenthood, creates a large and expanding market for modernized storage solutions.
TMRW's first-mover advantage with an FDA-cleared automated platform positions it to become the standard of care, with opportunities to expand into international markets and leverage its aggregated data for clinical insights.

Risk Factors

Key risks include slow adoption by conservative clinics, the high-stakes operational complexity of scaling hardware deployment and specimen management, and the existential liability risk associated with a potential storage failure.
The company also faces future competition from well-funded entrants attracted by the clear market need.

Competitive Landscape

TMRW operates in a niche with limited direct competitors offering a fully integrated, automated, and FDA-cleared platform. Traditional competition consists of manual storage in dewars from suppliers like Thermo Fisher, and basic barcode-based inventory systems. The primary competitive threat is from new entrants developing similar automated solutions, but TMRW's regulatory clearances and early clinic partnerships create a significant barrier to entry.